A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...

In this randomized clinical trial, adults with an alcohol use disorder (AUD) receiving either treatment as usual (TAU), ...

In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a ...

A history of mild traumatic brain injury (TBI) in healthy, middle-aged adults was associated with detectable changes in ...

In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...

In this randomized controlled trial, patients with metabolic syndrome who underwent time-restricted eating in addition to ...

In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that ...

Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...

In this secondary analysis of a stepped-wedge randomized trial, implementing strategies for suicide prevention concurrently ...

Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...

A newly found orthonairovirus, Wetland virus (WELV), was discovered to be pathogenic to humans, causing febrile illnesses in ...

In this randomized controlled trial, in patients diagnosed with migraine, it was found that administration of a monoclonal ...